To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Radiotherapy
Tuesday 17th March 2015

Asked by: Brian Binley (Conservative - Northampton South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment he has made of the potential effects on existing hospital services of the installation of proton beam therapy centres at (a) the Christie Hospital in Manchester and (b) University College London.

Answered by Jane Ellison

The installation of proton beam therapy centres at The Christie and University College London Hospitals will enable us to treat more patients than ever before.


Written Question
Radiotherapy
Tuesday 17th March 2015

Asked by: Brian Binley (Conservative - Northampton South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, where on the site of (a) the Christie Hospital in Manchester and (b) University College London the new proton beam therapy centres will be located.

Answered by Jane Ellison

The locations are as follows: the new proton beam therapy centre at The Christies, will be on the former Young Oncology site, Oak Road, Manchester, M20 3BA. The new proton beam therapy centre at University College London Hospitals will be on the former Rosenheim site on Grafton Way, London, WC1E 6DB.


Written Question
Radiotherapy
Tuesday 17th March 2015

Asked by: Brian Binley (Conservative - Northampton South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what forecast his Department has made of the likely cost per patient of receiving proton beam therapy treatment at one of the two planned centres for such therapy.

Answered by Jane Ellison

At full capacity, the estimated cost per patient receiving proton beam therapy in the United Kingdom is expected to be approximately £35,000.


Written Question
Radiotherapy
Tuesday 17th March 2015

Asked by: Brian Binley (Conservative - Northampton South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what his most recent estimate is of the likely cost of (a) construction and (b) annual operation of the proton beam therapy centre at the Christie Hospital in Manchester.

Answered by Jane Ellison

The Full Business Case for The Christie in Manchester indicates that the cost of construction will be £135.03 million and the annual operating costs (at full capacity) to be up to £24 million per year.


Written Question
Radiotherapy
Tuesday 17th March 2015

Asked by: Brian Binley (Conservative - Northampton South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what his most recent estimate is of the likely cost of (a) construction and (b) annual operation of the proton beam therapy centre at University College, London.

Answered by Jane Ellison

The Full Business Case for the University College London Hospitals indicates that the cost of construction will be £138.6 million and the annual operating costs (at full capacity) to be up to £25.5 million per year.


Written Question
Radiotherapy
Tuesday 17th March 2015

Asked by: Brian Binley (Conservative - Northampton South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what progress has been made on procuring proton beam therapy equipment for hospitals in the UK; when he plans to announce the supplier of proton beam therapy technology to the NHS; and what evaluation he has undertaken of the cost and clinical effectiveness of rival designs.

Answered by Jane Ellison

On 11 March 2015, the Department announced that Varian Medical Systems was the preferred supplier of proton beam therapy equipment for the new United Kingdom service on both sites. Evaluation of the bids included a thorough assessment of costs, technology and clinical effectiveness.